Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Dec;13(12):1157-61.
doi: 10.1007/BF00971633.

Effects of muscimol and baclofen on levels of monoamines and their metabolites in the El mouse brain

Affiliations

Effects of muscimol and baclofen on levels of monoamines and their metabolites in the El mouse brain

H Kabuto et al. Neurochem Res. 1988 Dec.

Abstract

We compared the changes in monoamines and their metabolites in the El mouse brain induced by GABA-A and GABA-B receptor agonists. Muscimol was used as a GABA-A receptor agonist, and baclofen as a GABA-B receptor agonist. Muscimol (3 mg/kg) significantly increased the DOPAC level in all parts of the mouse brain and the HVA level in the cortex, striatum, and midbrain. No significant change was observed in the dopamine (DA) level. These findings suggest that muscimol may accelerate both the synthesis and catabolism of DA. Baclofen (20 mg/kg) increased the DA level in the hippocampus and midbrain, and the DOPAC level in the hippocampus. Muscimol increased 5-HIAA levels and decreased 5-HT levels. This result suggests that 5-HT metabolism is accelerated by muscimol. No change in 5-HT or 5-HIAA levels was induced by baclofen. The GABA-A receptor system seems to have a potent effect not only on DA neurons, but on 5-HT neurons. However, the GABA-B receptor system appears to have almost no effect on 5-HT neurons, though it appears to have some effect on DA neurons.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Neuropharmacology. 1985 Mar;24(3):217-22 - PubMed
    1. Med Biol. 1975 Jun;53(3):177-83 - PubMed
    1. Br J Pharmacol. 1987 Jul;91(3):517-22 - PubMed
    1. Brain Res. 1986 Jul 9;377(2):362-7 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1984 Jun;326(2):99-105 - PubMed